These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1610 related items for PubMed ID: 26892957

  • 1. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG.
    Circ Res; 2016 Feb 19; 118(4):547-63. PubMed ID: 26892957
    [Abstract] [Full Text] [Related]

  • 2. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD.
    Curr Diab Rep; 2019 Nov 21; 19(12):146. PubMed ID: 31754844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review.
    Sascău R, Clement A, Radu R, Prisacariu C, Stătescu C.
    Nutrients; 2021 May 22; 13(6):. PubMed ID: 34067469
    [Abstract] [Full Text] [Related]

  • 9. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS, Vasan RS, Xanthakis V.
    J Am Heart Assoc; 2019 Jun 04; 8(11):e011433. PubMed ID: 31137992
    [Abstract] [Full Text] [Related]

  • 10. Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
    Wadström BN, Wulff AB, Pedersen KM, Nordestgaard BG.
    Curr Atheroscler Rep; 2023 Nov 04; 25(11):795-803. PubMed ID: 37768410
    [Abstract] [Full Text] [Related]

  • 11. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease.
    Brinton EA.
    Cardiol Clin; 2015 May 04; 33(2):309-23. PubMed ID: 25939302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.
    Björnson E, Adiels M, Gummesson A, Taskinen MR, Burgess S, Packard CJ, Borén J.
    J Am Coll Cardiol; 2024 Oct 01; 84(14):1328-1338. PubMed ID: 39322327
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
    Varbo A, Benn M, Nordestgaard BG.
    Pharmacol Ther; 2014 Mar 01; 141(3):358-67. PubMed ID: 24287311
    [Abstract] [Full Text] [Related]

  • 17. Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective.
    Parhofer KG.
    Atheroscler Suppl; 2015 May 01; 18():109-11. PubMed ID: 25936313
    [Abstract] [Full Text] [Related]

  • 18. 2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.
    Goldberg IJ.
    Arterioscler Thromb Vasc Biol; 2018 Apr 01; 38(4):700-706. PubMed ID: 29419410
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.